Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response

被引：0

作者：

D'Anna, Stefano ^{[1
]}

Salpini, Romina ^{[1
]}

Degasperi, Elisabetta ^{[2
]}

Duca, Leonardo ^{[1
,3
]}

Anolli, Maria Paola ^{[2
]}

Piermatteo, Lorenzo ^{[1
]}

Sambarino, Dana ^{[2
]}

Borghi, Marta ^{[2
]}

Facchetti, Floriana ^{[2
]}

Silberstein, Francesca Ceccherini ^{[1
]}

Perbellini, Riccardo ^{[2
]}

Svicher, Valentina ^{[1
,3
]}

Lampertico, Pietro ^{[2
,4
]}

机构：

[1] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[3] Univ Roma Tor Vergata, Dept Biol, Rome, Italy

[4] CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-159

引用

页码：S1142 / S1142

页数：1

共 50 条

[41] Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks
Buti, M.
Wedemeyer, H.
Aleman, S.
Chulanov, V.
Morozov, V.
Sagalova, O.
Stepanova, T.
Gish, R. G.
Lloyd, A.
Kaushik, A. M.
Suri, V.
Manuilov, D.
Osinusi, A. O.
Flaherty, J.
Pandey, S.
Singh, B.
Lampertico, P.
DIGESTIVE AND LIVER DISEASE, 2023, 55 : S72 - S73
[42] Durability of sustained virological response in hepatitis C treated patients
Desmond, CP
Roberts, S
Nguyen, S
Dudley, F
Mitchell, J
Day, C
Bailey, M
Pianko, S
HEPATOLOGY, 2004, 40 (04) : 342A - 342A
[43] HBsAg seroconversion: Different kinetics of serum HBsAg level decrease in inactive carriers and chronic hepatitis B patients treated with interferon
Moucari, Rami
Mackiewicz, Vincent
Lada, Olivier
Devergne, Agnes
Boyer, Nathalie
Asselah, Tarik
Martinot-Peignoux, Michele
Vidaud, Michel
Nicolas-Chanoine, Marie-Helene
Marcellin, Patrick
HEPATOLOGY, 2007, 46 (04) : 680A - 680A
[44] HBsAg clearance in HBeAg negative infection and treated chronic hepatitis B is associated with different HBsAg kinetics
Colombatto, P.
Bleve, P.
Oliveri, F.
Cavallone, D.
Ricco, G.
Coco, B.
Romagnoli, V.
Salvati, A.
Bonino, F.
Brunetto, M. R.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : E27 - E28
[45] Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
Wedemeyer, Heiner
Aleman, Soo
Andreone, Pietro
Blank, Antje
Brunetto, Maurizia
Bogomolov, Pavel
Chulanov, Vladimir
Geyvandova, Natalia
Hilgard, Gudrun
Mamonova, Nina
Merle, Uta
Viacheslav, Morozov
Sagalova, Olga
Stepanova, Tatyana
zur Wiesch, Julian Schulze
Zotov, Sergey
Zeuzem, Stefan
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2021, 75 : S294 - S295
[46] Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C
Maisonneuve, Patrick
Bruno, Savino
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (14): : 1457 - 1457
[47] Sustained Virological Response in Diabetic Patients with Chronic Hepatitis C
Dogan, Umit B.
Akin, Mustafa S.
Camuz, Gunay
HEPATOLOGY, 2014, 60 : 704A - 704A
[48] Baseline predictors of virological response for chronic hepatitis B patients
Xue-Jie Wu
World Journal of Gastroenterology, 2009, 15 (34) : 4311 - 4315
[49] Baseline predictors of virological response for chronic hepatitis B patients
Wu, Xue-Jie
Wang, Yan
Chen, Ji
Wang, Gui-Qiang
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (34) : 4311 - 4315
[50] Kinetics of hepatitis B core related antigen in patients with compensated HDV cirrhosis treated with Bulevirtide monotherapy for 72 weeks: a single-center study
Degasperi, Elisabetta
Anolli, Maria Paola
Sambarino, Dana
Facchetti, Floriana
Scholtes, Caroline
Renteria, Sara Colonia Uceda
Perego, Alberto
Orsini, Corinna
Charre, Caroline
Plissonnier, Marie-Laure
Ceriotti, Ferruccio
Monico, Sara
Testoni, Barbara
Levrero, Massimo
Zoulim, Fabien
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2023, 78 : S1170 - S1170

← 1 2 3 4 5 →